The pharmaceutical sector is under stress: globally, research budgets are decreasing, and research and development sites are closing. New R&D models are required to ensure the development of drugs to treat diseases like Alzheimer\u2019s and mental illness. The Structural Genomics Consortium, founded in 2003, works to identify proteins that are potential drug targets \u2013 one of the most important parts of drug discovery. Under their unique research model, researchers and the private sector collaborate and share results globally through an \u201copen access\u201d (no patents) R&D approach.<\/p>\n
Dr. Aled Edwards oversees the Structural Genomics Consortium (SGC). Trained as a protein biochemist at McGill and Stanford Universities, his teams are responsible for approximately 20% of the global output of human protein structures. As Chief Executive of the SGC, Al has overseen the growth of the organization from its inception. He is also Banbury Professor of Medical Research at the University of Toronto. Al’s interests include genomics and proteomics, the economics of drug discovery, the role of intellectual property in innovation, and science outreach. He was the Scientific Advisor to the award-winning international TV science
\ndrama, ReGenesis.<\/p>\n
<\/p>\n
Le secteur pharmaceutique est en difficult\u00e9 : partout dans le monde, les budgets de recherche diminuent et les installations de recherche et d\u00e9veloppement (R et D) ferment leurs portes. De nouveaux mod\u00e8les de R et D sont requis afin d\u2019assurer la mise au point de nouveaux m\u00e9dicaments pour traiter des affections telles que la maladie d\u2019Alzheimer et la maladie mentale. Fond\u00e9 en 2003, le Structural Genomics Consortium (SGC) travaille \u00e0 cerner des prot\u00e9ines qui sont des cibles m\u00e9dicamenteuses potentielles. Il s\u2019agit de l\u2019une des facettes les plus importantes de la d\u00e9couverte de nouveaux m\u00e9dicaments. En vertu du mod\u00e8le de recherche unique du SGC, les chercheurs et le secteur priv\u00e9 collaborent et \u00e9changent les r\u00e9sultats de leur recherche \u00e0 l\u2019\u00e9chelle mondiale par l\u2019entremise d\u2019une approche de libre acc\u00e8s (pas de brevets) \u00e0 la R et D.<\/p>\n
Aled Edwards, qui a suivi une formation en biochimie des prot\u00e9ines \u00e0 l\u2019Universit\u00e9 McGill et \u00e0 la Stanford University, dirige le SGC. Ses \u00e9quipes et lui g\u00e9n\u00e8rent environ 20 p. 100 des donn\u00e9es mondiales sur les structures de prot\u00e9ines humaines. En tant que directeur g\u00e9n\u00e9ral du SGC, M. Edwards a veill\u00e9 \u00e0 la croissance de l\u2019organisme depuis sa cr\u00e9ation. Il est titulaire de la chaire Banbury en recherche m\u00e9dicale et professeur au D\u00e9partement de biophysique m\u00e9dicale de la University of Toronto. Les int\u00e9r\u00eats de M. Edwards comprennent la g\u00e9nomique et la prot\u00e9omique, l\u2019\u00e9conomie de la d\u00e9couverte de m\u00e9dicaments, le r\u00f4le de la propri\u00e9t\u00e9 intellectuelle dans l\u2019innovation et la sensibilisation aux sciences. Il a notamment \u00e9t\u00e9 conseiller scientifique pour la s\u00e9rie t\u00e9l\u00e9vis\u00e9e prim\u00e9e internationalement ReGenesis.<\/p>","excerpt":"","slug":"dr-aled-edwards-human-genomics-and-new-models-for-drug-discovery-la-genomique-humaine-et-les-nouveaux-modeles-de-decouverte-de-medicaments","image":false,"all_day":false,"start_date":"2012-11-22 07:15:00","start_date_details":{"year":"2012","month":"11","day":"22","hour":"07","minutes":"15","seconds":"00"},"end_date":"2012-11-22 08:15:00","end_date_details":{"year":"2012","month":"11","day":"22","hour":"08","minutes":"15","seconds":"00"},"utc_start_date":"2012-11-22 12:15:00","utc_start_date_details":{"year":"2012","month":"11","day":"22","hour":"12","minutes":"15","seconds":"00"},"utc_end_date":"2012-11-22 13:15:00","utc_end_date_details":{"year":"2012","month":"11","day":"22","hour":"13","minutes":"15","seconds":"00"},"timezone":"America\/Toronto","timezone_abbr":"EST","cost":"","cost_details":{"currency_symbol":"","currency_code":"","currency_position":"prefix","values":[]},"website":"","show_map":true,"show_map_link":true,"hide_from_listings":false,"sticky":false,"featured":false,"categories":[],"tags":[],"venue":[],"organizer":[{"id":2226,"author":"2","status":"publish","date":"2020-09-24 11:04:19","date_utc":"2020-09-24 15:04:19","modified":"2020-09-30 15:07:02","modified_utc":"2020-09-30 19:07:02","url":"https:\/\/pagse.org\/organisateur\/the-partnership-group-for-science-and-engineering\/","organizer":"The Partnership Group for Science and Engineering\/Le Partenariat en faveur des sciences et de la technologie","slug":"the-partnership-group-for-science-and-engineering","json_ld":{"@type":"Person","name":"The Partnership Group for Science and Engineering\/Le Partenariat en faveur des sciences et de la technologie","description":"","url":"","telephone":"","email":"","sameAs":""},"global_id":"pagse.org\/fr\/?id=2226","global_id_lineage":["pagse.org\/fr\/?id=2226"]}],"json_ld":{"@context":"http:\/\/schema.org","@type":"Event","name":"Dr. Aled Edwards: Human Genomics and New Models for Drug Discovery | La ge\u0301nomique humaine et les nouveaux mode\u0300les de de\u0301couverte de me\u0301dicaments","description":"<p>The pharmaceutical sector is under stress: globally, research budgets are decreasing, and research and development sites are closing. New R&D models are required to ensure the development of drugs to […]<\/p>\\n","url":"https:\/\/pagse.org\/fr\/event\/dr-aled-edwards-human-genomics-and-new-models-for-drug-discovery-la-genomique-humaine-et-les-nouveaux-modeles-de-decouverte-de-medicaments\/","eventAttendanceMode":"https:\/\/schema.org\/OfflineEventAttendanceMode","eventStatus":"https:\/\/schema.org\/EventScheduled","startDate":"2012-11-22T07:15:00-05:00","endDate":"2012-11-22T08:15:00-05:00","organizer":{"@type":"Person","name":"The Partnership Group for Science and Engineering\/Le Partenariat en faveur des sciences et de la technologie","description":"","url":"","telephone":"","email":"","sameAs":""},"performer":"Organization"}}